The Pivot Point: How Modular Medical (NASDAQ: MODD) Is Betting on the 70% of Diabetics That Big Insulin Forgot -( $MODD $PODD $MDT $TNDM ) by John F. Heerdink, Jr. 8 hours ago Read more Trump Goes Down Under: How Aussie-Style Retirements Could Supercharge Wall Street’s Long Game -( $AMWL $MODD ) by John F. Heerdink, Jr. 2 days ago Read more Biotech Sizzles While Beef Soars: Why Investors Are Buying Labs, Not Ribeyes -( $AMWL $EPRX $MODD $XBI ) by John F. Heerdink, Jr. 4 days ago Read more From Couch to $50 Copay: Medicare’s Bridge Program and the Long‑Only Case for Obesity as a Chronic‑Care Asset Class -( $LLY MODD $NVO ) by John F. Heerdink, Jr. July 5, 2026 Read more Soft Landing, Hard Numbers: Why a 57,000‑Job Economy May Love $RIVN, $SMWB, and $MODD by John F. Heerdink, Jr. July 2, 2026 Read more Cooler Jobs, Hotter Trades: What A Sub‑100K Payroll Print Can Mean For Your Risk Book-( $LLY $MODD $SMWB $TSM ) by John F. Heerdink, Jr. July 1, 2026 Read more When Simplicity Becomes a Moat: How Modular Medical’s Pivot Pump Could Reprice Diabetes Convenience -( $ABT $MODD $LLY ) by John F. Heerdink, Jr. July 1, 2026 Read more The ‘Almost‑Pumper’ Revolution: Modular Medical’s Pivot And The Art Of Making Diabetes Easier -( $MODD ) by John F. Heerdink, Jr. June 30, 2026 Read more Biotech, Insulin Pumps, & Power Boards: Four Chronic‑Care Plays Quietly Rewriting the Healthcare Script -( $ABVX $LLY $MMED $MODD ) by John F. Heerdink, Jr. June 30, 2026 Read more Needles Out, Pumps In: Modular’s Pivot and Insulet’s Omnipod Seek To Rewrite the Diabetes Playbook -( $MODD $PODD ) by John F. Heerdink, Jr. June 29, 2026 Read more Read more
